Mochi Health Review 2026: Cash-pay patients prioritizing flat, dose-independent pricing who accept compounded-medication tradeoffs
Our verdict
Mochi Health is a flat-fee obesity practice: membership is $79/month (a $39 first-month promotion was running at review time), with provider visits and messaging included. Its signature economics are compounded medications at one price for every dose: $99/month for compounded semaglutide and $199/month for compounded tirzepatide, shipping included, so costs do not rise as doses titrate. Mochi can also prescribe branded Wegovy or Zepbound and coordinates insurance approvals. The appeal is real, including board-certified obesity-medicine physicians and predictable pricing; the tradeoff is regulatory. Since the FDA declared the semaglutide and tirzepatide shortages resolved in 2025, mass-compounded copies sit on uncertain legal ground, and a poison-center case series documented 10-fold dosing errors with compounded semaglutide vials. Compounded drugs are not FDA-reviewed for safety, effectiveness, or quality, and membership bills even while you wait on insurance approval. Every medication requires a provider evaluation, a prescription, and BMI-based eligibility.
Score breakdown
- Safety (30%)7.5/10
- Evidence (30%)5.5/10
- Cost & Value (20%)8.5/10
- Transparency (10%)8.5/10
- Support (10%)7.5/10
Scored per our review methodology.
Who it's for
Best for: Cash-pay patients prioritizing flat, dose-independent pricing who accept compounded-medication tradeoffs.
Pricing
$79/mo membership ($39 first month promo) + compounded semaglutide $99/mo or compounded tirzepatide $199/mo (all doses, shipping included); branded Wegovy/Zepbound also prescribable
| Plan | Price | Notes |
|---|---|---|
| Mochi Health membership | $79/mo ($39 first month promo); 12 months $799 | Provider visits, messaging, and care coordination included; medication separate |
| Compounded semaglutide | $99/mo, all doses (0.22-2.67 mg weekly), shipping included | Compounded drugs are not FDA-reviewed for safety, effectiveness, or quality |
| Compounded tirzepatide | $199/mo, all doses (2.2-16.6 mg weekly), shipping included | Branded Wegovy/Zepbound prescribable as alternatives, incl. via insurance |
What the evidence says
- A poison control center case series documented adverse events after patients self-administered 10-fold overdoses of compounded semaglutide drawn from vials. (J Am Pharm Assoc case series: compounded semaglutide administration errors)
- Post-shortage, compounded GLP-1 receptor agonists face restricted legal availability and documented quality-control and dosing-error concerns. (PMC review: The Future of Compounded GLP-1 Receptor Agonists for Weight Loss)
- FDA-approved tirzepatide produced up to 20.9% mean body-weight reduction at 72 weeks in the SURMOUNT-1 trial; compounded copies have no equivalent trial data. (SURMOUNT-1 trial (NEJM 2022): Tirzepatide Once Weekly for the Treatment of Obesity)
Pros & cons
Pros
- Flat medication pricing at every dose: $99/mo compounded semaglutide, $199/mo compounded tirzepatide, shipping included
- Care led by board-certified obesity-medicine physicians with regular synchronous visits
- Membership covers unlimited visits and messaging with no per-visit fees
- Can prescribe branded Wegovy/Zepbound and offers interim options while insurance approval is pending
- Unusually transparent FAQ that publishes exact membership and medication prices
Cons & red flags
- Red flag: the core offering is compounded semaglutide and tirzepatide, which are not FDA-reviewed for safety, effectiveness, or quality, and whose legal availability is uncertain now that the FDA shortages resolved in 2025 ended the main basis for mass compounding
- Compounded vials lack the dosing safeguards of manufactured pens; a published poison-center case series documented 10-fold dosing errors with compounded semaglutide
- The $79/month membership bills even while you are waiting for insurance approval or between medication fills
- Total cost with tirzepatide ($278/month) approaches branded entry-dose pricing available elsewhere
How it compares
Mochi Health scores 7.2/10 in our weight loss evaluation. See where it lands in the full ranking: Best Weight-Loss Supplements of 2026.
- Ro (Ro Body) review — 8.4/10, cash-pay patients who want branded glp-1s at manufacturer direct rates with insurance-coordination help
- WeightWatchers Clinic (WW Med+) review — 8.3/10, insured patients who want hands-on prior-authorization help plus a structured behavioral program
Frequently asked questions
How much is Mochi Health per month?
Membership is $79/month (or $799/year), with a $39 first-month promotion at the time of review. Medication is extra: $99/month for compounded semaglutide or $199/month for compounded tirzepatide at any dose, shipping included, so typical all-in costs are $178-$278/month.
Is compounded semaglutide still legal in 2026?
It occupies a gray zone. Mass compounding was permitted while FDA listed semaglutide and tirzepatide in shortage; those shortages were declared resolved in 2025, so compounders may now only prepare versions for patients whose medical needs cannot be met by the FDA-approved product. Compounded copies are not FDA-reviewed for safety, effectiveness, or quality.
Does Mochi Health take insurance?
The membership is cash-pay, but Mochi's care team coordinates insurance approval for branded medications like Wegovy and Zepbound and can offer interim options while prior authorization is pending.
(affiliate link)
Get evidence-based health picks in your inbox — no hype.
Join The Firsthand Brief for a weekly, research-first read.
We never sell your email. Unsubscribe anytime. See our privacy policy.